DE2524278A1 - Diagnostisches mittel, hilfsmittel zu dessen herstellung sowie diagnoseverfahren - Google Patents

Diagnostisches mittel, hilfsmittel zu dessen herstellung sowie diagnoseverfahren

Info

Publication number
DE2524278A1
DE2524278A1 DE19752524278 DE2524278A DE2524278A1 DE 2524278 A1 DE2524278 A1 DE 2524278A1 DE 19752524278 DE19752524278 DE 19752524278 DE 2524278 A DE2524278 A DE 2524278A DE 2524278 A1 DE2524278 A1 DE 2524278A1
Authority
DE
Germany
Prior art keywords
particles
water
polysaccharide
substituents
bridges
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752524278
Other languages
German (de)
English (en)
Inventor
Bernt Jabes Lindberg
Ulv Sen Erik Dr Rothman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of DE2524278A1 publication Critical patent/DE2524278A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C08B31/006—Crosslinking of derivatives of starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE19752524278 1974-06-06 1975-05-31 Diagnostisches mittel, hilfsmittel zu dessen herstellung sowie diagnoseverfahren Withdrawn DE2524278A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7407461A SE420566B (sv) 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering

Publications (1)

Publication Number Publication Date
DE2524278A1 true DE2524278A1 (de) 1975-12-18

Family

ID=20321348

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752524278 Withdrawn DE2524278A1 (de) 1974-06-06 1975-05-31 Diagnostisches mittel, hilfsmittel zu dessen herstellung sowie diagnoseverfahren

Country Status (8)

Country Link
JP (1) JPS517113A (https=)
AU (1) AU8164675A (https=)
CA (1) CA1039274A (https=)
DE (1) DE2524278A1 (https=)
FR (1) FR2273516A1 (https=)
GB (1) GB1518813A (https=)
NL (1) NL7506743A (https=)
SE (1) SE420566B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983001738A1 (en) * 1981-11-12 1983-05-26 SCHRÖDER, Ulf Intravascularly administrable, magnetically responsive nanosphere or manoparticle, a process for the production thereof, and the use thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548902B1 (fr) * 1983-07-13 1986-04-11 Guerbet Sa Gel pour embolisation therapeutique
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983001738A1 (en) * 1981-11-12 1983-05-26 SCHRÖDER, Ulf Intravascularly administrable, magnetically responsive nanosphere or manoparticle, a process for the production thereof, and the use thereof

Also Published As

Publication number Publication date
CA1039274A (en) 1978-09-26
SE7407461L (sv) 1975-12-08
GB1518813A (en) 1978-07-26
FR2273516A1 (fr) 1976-01-02
SE420566B (sv) 1981-10-19
FR2273516B1 (https=) 1979-01-05
JPS517113A (https=) 1976-01-21
NL7506743A (nl) 1975-12-09
AU8164675A (en) 1976-12-02

Similar Documents

Publication Publication Date Title
DE2524279C2 (https=)
DE69817008T2 (de) Niedrigtemperaturschichten
DE60025328T2 (de) Verfahren zur herstellung von mehrfach vernetzten hyaluronsäurederivaten
DE60316291T2 (de) Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtung
DE68917009T2 (de) Sulfaminoderivate von Chondroitinsulfat, Dermatansulfat und Hyaluronsäure und ihre pharmakologischen Eigenschaften.
DE69611418T2 (de) Tabakrauchfilter und Verfahren zur deren Herstellung
DE69724001T2 (de) Superabsorbierendes material und verfahren zu dessen herstellung
US4406878A (en) Iodinated contrast agent for radiography
DE2634539C2 (de) Verfahren zur Herstellung von saugfähigen, modifizierten Stärkeethern und deren Verwendung
DE2723878C2 (https=)
DE69431800T2 (de) Arzneiverabreichungssystem
EP0330134A1 (de) Modifizierte Cellulose für biocompatible Dialysemembranen IV und Verfahren zu deren Herstellung
DE3434104A1 (de) Wasserunloesliche zubereitung von hyaluronsaeure und verfahren dazu
DE4442606C2 (de) Quellbarer Stärkeester, Verfahren zu dessen Herstellung sowie Verwendung
DE3337443A1 (de) Den ph-wert regulierende materialien und ihre herstellung
EP1732953B1 (de) Hydroxyethylstärke
US4126669A (en) Diagnostic agent
DE2542255A1 (de) Mittel zur intravaskulaeren verabreichung
DE69223587T2 (de) Carboxyalkylpolysaccharide und Verfahren zu ihrer Herstellung
DE19654745C5 (de) Biologisch abbaubares Absorptionsmittel, dessen Herstellung und Verwendung
DE68904617T2 (de) Jodhaltige polymere mit skeletten von dextran, verfahren zu ihrer herstellung und ihre verwendungen als kontrastmittel.
WO2000012590A1 (de) Verfahren zur herstellung von sphärischen mikropartikeln, die ganz oder teilweise aus mindestens einem wasserunlöslichen verzweigungen enthaltenden polyglucan bestehen, sowie mit diesem verfahren erhältliche mikropartikel
EP0714913A1 (de) Quellbarer Stärkeester, Verfahren zu dessen Herstellung sowie Verwendung
DE2346774A1 (de) Roentgenkontrastmittel
EP2506858B1 (de) Stärkederivatmischungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8130 Withdrawal